# Deciphering the Complex Relationships Between the Hemostasis System and Infective Endocarditis

**Authors:** Muhammad Aamir Wahab, Atta Ullah Khan, Silvia Mercadante, Iolanda Cafarella, Lorenzo Bertolino, Emanuele Durante-Mangoni

PMC · DOI: 10.3390/jcm14113965 · Journal of Clinical Medicine · 2025-06-04

## TL;DR

This paper reviews how the coagulation system interacts with infective endocarditis, focusing on mechanisms and treatment challenges.

## Contribution

The paper provides a comprehensive review of pathogen-specific coagulation profiles and clinical implications in infective endocarditis.

## Key findings

- Staphylococcus aureus alters coagulation through platelet activation and prothrombin stimulation.
- Dysregulated coagulation in IE contributes to vegetation formation and thromboembolic complications.
- Tailoring antiplatelet and anticoagulant therapy is critical due to patient comorbidities and IE-related risks.

## Abstract

Infective endocarditis (IE) arises from complex interactions between microbial pathogens and host hemostasis systems, where dysregulated coagulation mediates microbial persistence and systemic thromboembolic complications. Alterations in primary, secondary, and tertiary hemostasis in the acute IE phase have direct clinical implications for vegetation formation and detachment. Staphylococcus aureus is one of the most common pathogens that causes IE, and it is capable of profoundly altering the coagulation cascade through several mechanisms, such as platelet activation, prothrombin activation through staphylocoagulase release, and plasminogen stimulation via staphylokinase production. Understanding these complex and yet unmasked mechanisms is of pivotal importance to promoting targeted therapeutic intervention aimed at reducing IE morbidity and mortality. Moreover, the management of antiplatelet and anticoagulant treatment during IE onset is a controversial issue and needs to be tailored to patient comorbidities and IE-related complications, such as cerebral embolism. This review provides a roadmap to promote clinicians’ understanding of the complex interactions between hemostasis and IE clinical manifestations and complications, discussing pathogen-specific coagulation profiles while addressing critical knowledge gaps for IE management.

## Linked entities

- **Diseases:** infective endocarditis (MONDO:0000565)
- **Species:** Staphylococcus aureus (taxon 1280)

## Full-text entities

- **Genes:** PLG (plasminogen) [NCBI Gene 5340] {aka HAE4}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** IE (MESH:D004696), cerebral embolism (MESH:D020766), thromboembolic complications (MESH:D013923)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12156263/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12156263/full.md

## References

163 references — full list in the complete paper: https://tomesphere.com/paper/PMC12156263/full.md

---
Source: https://tomesphere.com/paper/PMC12156263